drugset / Trial / NCT00511667
A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)
RandomizedParallel-groupDouble-blindTreatment
Summary
A multiple dose study to assess the safety and pharmacokinetics of an investigational drug in patients with type 2 diabetes. The primary hypotheses of the study are that multiple daily MK-0941 in subjects with T2DM with or without adequate control on metformin will be sufficiently safe and well tolerated to permit continued clinical investigation.
Timeline
- Start
- 2007-05
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-0941 | Small molecule | 10 mg | — |
| Subject | MK-0941 | Small molecule | 20 mg | — |
| Subject | MK-0941 | Small molecule | 30 mg | — |
| Subject | MK-0941 | Small molecule | 40 mg | — |
| Subject | MK-0941 | Small molecule | 60 mg | — |